Home | Optionality

Making you smarter about the Stock Market.
Get the 5-min newsletter that Wall Street reads.
Thank us later. ⚡️

Join our newsletter below.

You’ll also receive a free gift in your inbox. 🎁

Rivian stock surges in biggest rally ever as software business shines

Feb 16, 2026

•

3 min read

Rivian stock surges in biggest rally ever as software business shines

Rivian $RIVN delivered its strongest stock market performance since going public, soaring more than 25% in a single day despite a brutal environment for electric vehicle makers

Wendy’s to close hundreds of restaurants after steep sales decline

Feb 16, 2026

•

2 min read

Wendy’s to close hundreds of restaurants after steep sales decline

Wendy’s $WEN is shrinking its US footprint as traffic collapses, with plans to shut down roughly 5% to 6% of locations, about 300 restaurants, in the first half of 2026. T

Warner Bros. weighs reopening talks with Paramount despite existing Netflix deal

Feb 16, 2026

•

2 min read

Warner Bros. weighs reopening talks with Paramount despite existing Netflix deal

Warner Bros. Discovery $WBD is reportedly reconsidering merger negotiations with Paramount $PSKY after the company sweetened its takeover proposal, even though WBD already signed a binding agreement with Netflix $NFLX late last year. Paramount did not raise its $30-per-share cash offer, but added new incentives that significantly improve the total package

Feb 13, 2026

•

14 min read

😓Coinbase $667 Million Loss

+ US Inflation Cools to 2.4% in January as Gas Prices Fall but Core Costs Stay Sticky

Regulators scrutinize pharmacy tied to Hims GLP-1 drug after new complaints surface

Feb 13, 2026

•

3 min read

Regulators scrutinize pharmacy tied to Hims GLP-1 drug after new complaints surface

State regulators are intensifying scrutiny of Strive Pharmacy, a major compounding partner for telehealth companies including Hims & Hers $HIMS, following fresh allegations involving ketamine misuse and improper drug distribution. The investigation comes on top of existing concerns about how Strive compounded copycat versions of blockbuster weight-loss drugs originally developed by Eli Lilly $LLY and Novo Nordisk $NVO .

Meta plans facial recognition comeback in smart glasses push

Feb 13, 2026

•

2 min read

Meta plans facial recognition comeback in smart glasses push

Meta $META is reportedly bringing back facial recognition technology, this time embedded directly into its smart glasses. The company had previously scrapped similar software in 2021 amid privacy backlash, but internal documents suggest it now plans to reintroduce the capability as early as this year.

January inflation comes in softer than feared, easing pressure on markets

Feb 13, 2026

•

2 min read

January inflation comes in softer than feared, easing pressure on markets

Fresh inflation data offered a rare bit of good news: prices didn’t spike at the start of the year. The Consumer Price Index showed headline inflation rising 0.2% month over month, while core inflation, which strips out food and energy, increased 0.3% both slightly below expectations.

Apple stock drops as investors worry about AI execution, not spending

Feb 13, 2026

•

2 min read

Apple stock drops as investors worry about AI execution, not spending

Apple $AAPL slid sharply after a broader tech selloff, posting its worst single-day decline in months and underperforming most of its Big Tech peers. Unlike rivals pouring hundreds of billions into AI infrastructure, Apple has actually reduced capital spending and remains less exposed to fears of runaway AI costs.

Applied Materials stock surges after blowout quarter sparks wave of price target hikes

Feb 13, 2026

•

3 min read

Applied Materials stock surges after blowout quarter sparks wave of price target hikes

Applied Materials $AMAT soared after delivering a blockbuster earnings report that convinced Wall Street the company is a major beneficiary of the AI chip boom. The semiconductor equipment giant beat expectations on both revenue and profit and issued Q2 guidance that also topped estimates, sending shares sharply higher in early trading.

SharkNinja hits record high as viral gadgets drive explosive growth

Feb 13, 2026

•

2 min read

SharkNinja hits record high as viral gadgets drive explosive growth

SharkNinja $SN is riding a red-hot streak, sending shares to an all-time high after reporting an “outstanding holiday season” and a blockbuster 2025.

Moderna beats Q4 estimates and forecasts stronger 2026 sales despite regulatory hurdles

Feb 13, 2026

•

2 min read

Moderna beats Q4 estimates and forecasts stronger 2026 sales despite regulatory hurdles

Moderna $MRNA delivered fourth-quarter results that topped Wall Street expectations and issued an optimistic outlook for 2026, even as the company faces mounting regulatory challenges. The biotech reported a loss of $2.11 per share, narrower than the expected $2.54 loss, on revenue of $678 million, comfortably above forecasts of $635 million.

Plug Power shareholders approve share increase, clearing path for new capital raises

Feb 13, 2026

•

2 min read

Plug Power shareholders approve share increase, clearing path for new capital raises

Plug Power $PLUG secured shareholder approval to increase its authorized share count, a move that allows the hydrogen fuel cell company to raise fresh capital without resorting to a reverse stock split.

Pinterest stock sinks after weak Q1 outlook and ad slowdown fears

Feb 13, 2026

•

2 min read

Pinterest stock sinks after weak Q1 outlook and ad slowdown fears

Pinterest $PINS shares plunged in premarket trading after the company issued a disappointing first-quarter sales forecast, overshadowing an otherwise steady fourth-quarter report. While Q4 revenue rose 14% year over year to $1.32 billion, roughly in line with expectations, earnings per share of $0.67 came in slightly below forecasts.

DraftKings stock tumbles after weak 2026 outlook overshadows solid Q4

Feb 13, 2026

•

2 min read

DraftKings stock tumbles after weak 2026 outlook overshadows solid Q4

DraftKings $DKNG shares sank in after-hours trading after the sports betting giant issued disappointing forecasts for 2026, even though its fourth-quarter results met or beat expectations. The company projected full-year revenue between $6.5 billion and $6.9 billion, well below Wall Street’s $7.29 billion estimate, triggering a sharp selloff of roughly 15%.

Rivian beats Q4 expectations and prepares to launch its mass-market R2 SUV

Feb 13, 2026

•

3 min read

Rivian beats Q4 expectations and prepares to launch its mass-market R2 SUV

Rivian $RIVN shares jumped in after-hours trading after the electric vehicle maker delivered fourth-quarter results that beat Wall Street’s expectations, even as overall revenue declined year over year. The company reported $1.29 billion in Q4 revenue, topping estimates of $1.26 billion despite a 26% drop from last year, while its adjusted loss of $0.54 per share was narrower than the expected $0.68 loss.

Arista Networks tops earnings estimates and issues strong sales outlook

Feb 13, 2026

•

2 min read

Arista Networks tops earnings estimates and issues strong sales outlook

Arista Networks $ANET surged in after-hours trading after delivering a fourth-quarter report that beat Wall Street on both profit and revenue, while also issuing upbeat guidance for the months ahead. The data center networking company posted adjusted earnings per share of $0.82, comfortably above the $0.76 analysts expected, alongside revenue of $2.49 billion versus forecasts of $2.38 billion.

Coinbase reports record stablecoin revenue but misses Q4 sales expectations

Feb 13, 2026

•

3 min read

Coinbase reports record stablecoin revenue but misses Q4 sales expectations

Coinbase $COIN is rising in premarket trading, up more than 6%, even after delivering a fourth-quarter report that fell short of Wall Street’s expectations and swung to a sizable loss. The crypto exchange posted revenue of $1.78 billion, missing the $1.81 billion analysts were looking for, while adjusted earnings per share dropped sharply from a year ago.

Feb 12, 2026

•

14 min read

₿ Bitcoin $50K?

+ Nebius Misses Q4 Estimates but Doubles Down on AI Power Expansion

Anthropic Raises $30B at $380B Valuation as Claude Revenue Hits $14B Run Rate

Feb 12, 2026

•

2 min read

Anthropic Raises $30B at $380B Valuation as Claude Revenue Hits $14B Run Rate

Anthropic has closed a massive $30 billion Series G round, pushing its post money valuation to $380 billion. The raise cements the company as one of the most valuable private AI firms in the world.

Jobs or GPUs? Big Tech’s $680B AI Bill Could Pressure Tech Workers

Feb 12, 2026

•

3 min read

Jobs or GPUs? Big Tech’s $680B AI Bill Could Pressure Tech Workers

Big Tech’s AI spending spree is about to hit the income statement. After pouring hundreds of billions into data centers and GPUs, companies like Meta $META , Microsoft $MSFT , Alphabet $GOOGL , and Oracle $ORCL are preparing to absorb a tidal wave of depreciation costs.

Anthropic Commits $20M to Pro-Regulation AI PAC as Washington Battle Escalates

Feb 12, 2026

•

2 min read

Anthropic Commits $20M to Pro-Regulation AI PAC as Washington Battle Escalates

The fight over artificial intelligence policy is shifting from Silicon Valley to Capitol Hill. Anthropic is donating $20 million to Public First Action, a new super PAC focused on promoting AI regulation centered on public safety.